GPR109A and Parkinson’s Disease: Role of Niacin in Outcome Measures
Condition(s):Parkinson’s DiseaseLast Updated:November 17, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Parkinson’s DiseaseLast Updated:November 17, 2021Completed
Condition(s):Parkinson’s DiseaseLast Updated:January 23, 2024Terminated
Condition(s):Contact Dermatitis of HandsLast Updated:January 6, 2020Completed
Condition(s):Delayed Graft FunctionLast Updated:October 18, 2022Not yet recruiting
Condition(s):Ataxia Telangiectasia; ATM Gene MutationLast Updated:July 25, 2022Completed
Condition(s):Progressive Supranuclear PalsyLast Updated:April 10, 2017Completed
Condition(s):Central Retinal Vein Occlusion; Branch Retinal Vein OcclusionLast Updated:November 13, 2019Terminated
Condition(s):HyperphosphatemiaLast Updated:July 30, 2007Completed
Condition(s):Migraine ProphylaxisLast Updated:January 17, 2024Recruiting
Condition(s):Hand-Foot Skin Reaction (HFSR)Last Updated:April 1, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.